Jing Yao Selected Research

7- O- (2,6- dideoxy- 2- fluorotalopyranose)adriamycinone (DFTA)

10/2019

Intracellular cascade activated nanosystem for improving ER+ breast cancer therapy through attacking GSH-mediated metabolic vulnerability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jing Yao Research Topics

Disease

83	Neoplasms (Cancer) 09/2022 - 12/2010
17	Inflammation (Inflammations) 01/2022 - 09/2009
13	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2008
12	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2014
12	Infections 02/2022 - 01/2014
12	Neoplasm Metastasis (Metastasis) 10/2021 - 01/2014
6	Pain (Aches) 01/2022 - 09/2009
6	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 08/2012
5	Hemorrhage 02/2020 - 03/2013
5	Hypoxia (Hypoxemia) 01/2016 - 09/2008
4	Necrosis 10/2022 - 03/2013
4	COVID-19 03/2021 - 01/2020
4	Lung Injury 12/2018 - 10/2014
4	Colonic Neoplasms (Colon Cancer) 06/2015 - 07/2012
3	Reperfusion Injury 10/2022 - 07/2012
3	Fibrosis (Cirrhosis) 01/2022 - 01/2018
3	Colitis 02/2020 - 03/2015
3	Melanoma (Melanoma, Malignant) 01/2020 - 01/2014
3	Esophageal Squamous Cell Carcinoma 01/2019 - 05/2017
3	Carcinoma (Carcinomatosis) 06/2017 - 07/2012
3	Body Weight (Weight, Body) 01/2017 - 07/2012
3	Asthma (Bronchial Asthma) 03/2016 - 06/2015
2	Infarction (Infarctions) 10/2022 - 01/2018
2	Brain Ischemia (Cerebral Ischemia) 10/2022 - 07/2012
2	Hyperalgesia 01/2022 - 01/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 10/2005
2	Waardenburg Syndrome (Klein Syndrome) 06/2021 - 11/2017
2	Glaucoma 01/2021 - 07/2020
2	Virus Diseases (Viral Diseases) 01/2021 - 06/2016

Drug/Important Bio-Agent (IBA)

30	Pharmaceutical PreparationsIBA 10/2022 - 08/2012
13	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2013
12	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020 - 07/2012
11	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 08/2014
11	Therapeutic UsesIBA 01/2020 - 06/2015
9	FlavonoidsIBA 02/2020 - 01/2014
8	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 12/2010
8	wogoninIBA 12/2019 - 08/2013
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2022 - 09/2013
7	LipidsIBA 09/2022 - 09/2013
7	Antiviral Agents (Antivirals)IBA 01/2021 - 09/2013
7	Paclitaxel (Taxol)FDA LinkGeneric 02/2019 - 07/2012
7	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA 11/2014 - 07/2012
6	Biological ProductsIBA 02/2022 - 11/2015
6	LigandsIBA 01/2018 - 01/2013
5	Ion Channels (Ion Channel)IBA 01/2022 - 09/2009
5	Peptides (Polypeptides)IBA 01/2021 - 08/2015
5	SolutionsIBA 01/2020 - 07/2012
5	LipopolysaccharidesIBA 02/2019 - 10/2014
4	EnzymesIBA 02/2022 - 06/2015
4	Retinaldehyde (Retinal)IBA 01/2021 - 08/2006
4	InterleukinsIBA 11/2020 - 01/2017
4	CytokinesIBA 07/2020 - 10/2014
4	chrysinIBA 01/2020 - 06/2015
4	Angiogenesis InhibitorsIBA 02/2019 - 04/2016
4	Interleukin-6 (Interleukin 6)IBA 09/2018 - 10/2014
4	Hyaluronic Acid (Hyaluronan)IBA 01/2016 - 01/2013
3	GoldIBA 01/2022 - 02/2019
3	Capsaicin (Zostrix)FDA Link 01/2022 - 09/2009
3	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2015
3	Oxygen (Dioxygen)IBA 12/2021 - 01/2020
3	ChitosanIBA 01/2021 - 12/2008
3	InterferonsIBA 11/2020 - 06/2016
3	AntioxidantsIBA 01/2020 - 01/2014
3	BerberineIBA 01/2020 - 09/2015
3	Estrogen ReceptorsIBA 01/2020 - 01/2019
3	AcidsIBA 01/2020 - 07/2012
3	Capsules (Microcapsules)IBA 01/2019 - 09/2008
3	tocophersolanIBA 01/2019 - 05/2017
3	Drug CarriersIBA 08/2018 - 07/2012
3	Messenger RNA (mRNA)IBA 06/2018 - 07/2012
3	MicellesIBA 08/2017 - 06/2015
3	Glycyrrhetinic Acid (Po 12)IBA 08/2017 - 01/2013
3	Fluorouracil (Carac)FDA LinkGeneric 03/2017 - 08/2012
2	Hematoxylin (Haematoxylon)IBA 10/2022 - 03/2018
2	Eosine Yellowish-(YS) (Eosin)IBA 10/2022 - 03/2018
2	salicylhydroxamic acid (SHAM)IBA 10/2022 - 07/2012
2	SugarsIBA 09/2022 - 01/2020
2	Polyvinyl Chloride (PVC)IBA 02/2022 - 06/2013
2	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2007
2	TRPV Cation ChannelsIBA 01/2022 - 09/2009
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 12/2015
2	Coloring Agents (Dyes)IBA 01/2021 - 07/2012
2	IntegrinsIBA 01/2021 - 01/2016
2	CateninsIBA 01/2021 - 01/2018
2	Freund's AdjuvantIBA 01/2021 - 01/2018
2	VaccinesIBA 01/2021 - 01/2014
2	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 09/2018
2	Long Noncoding RNAIBA 01/2021 - 05/2017
2	GlucocorticoidsIBA 11/2020 - 06/2015

Therapy/Procedure

43	Therapeutics 09/2022 - 07/2012
15	Drug Therapy (Chemotherapy) 09/2022 - 07/2012
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2022 - 05/2013
4	Immunotherapy 02/2021 - 01/2014
3	Sutures (Suture) 11/2022 - 09/2021
3	Intravenous Administration 01/2014 - 01/2013
3	Transplantation 04/2011 - 12/2002
2	Aftercare (After-Treatment) 09/2022 - 01/2017
2	Phototherapy (Light Therapy) 03/2022 - 01/2021
2	Telescopes 01/2021 - 01/2020